Cigna Corp Company Top Insiders
| CI Stock | USD 265.30 -4.34 -1.61% |
| David Cordani CEO CEO and President Director and Member of Executive Committee |
| Isaiah Harris Chairman Independent Chairman of the Board |
Selling | Buying |
Latest Trades
| 2026-03-02 | Everett Neville | Disposed 1719 @ 288.91 | View | ||
| 2026-01-29 | Ro Khanna | Acquired @ 271.18 | |||
| 2026-01-13 | Ro Khanna | Acquired @ 271.77 | |||
| 2025-12-19 | Gilbert Ray Cisneros, Jr. | Acquired @ 272.11 | |||
| 2025-12-18 | Julie Johnson | Disposed @ 273.87 | |||
| 2025-11-13 | Julie Johnson | Disposed @ 270.54 | |||
| 2025-11-12 | Gilbert Ray Cisneros, Jr. | Disposed @ 270.99 | |||
| 2025-11-10 | Ro Khanna | Disposed @ 257.69 | |||
| 2025-11-03 | David Cordani | Acquired 4134 @ 241.88 | View | ||
| 2025-10-07 | Ro Khanna | Acquired @ 307.21 | |||
| 2025-10-03 | Brian C Evanko | Disposed 5368 @ 300 | View | ||
| 2025-09-29 | Ro Khanna | Disposed @ 286.39 | |||
| 2025-09-25 | Julie Johnson | Disposed @ 284.06 | |||
| 2025-09-23 | Val T. Hoyle | Disposed @ 289.87 | |||
| 2025-09-05 | Ro Khanna | Acquired @ 305.28 | |||
| 2025-08-15 | Nicole S Jones | Disposed 28526 @ 300 | View | ||
| 2025-08-14 | Julie Johnson | Disposed @ 290.55 | |||
| 2025-08-05 | Gilbert Ray Cisneros, Jr. | Disposed @ 271.17 | |||
| 2025-08-04 | Ro Khanna | Disposed @ 267.26 |
Acquired vs Disposed
Filed vs Not Filed
Cigna Corp's Workforce Through the Years
A workforce review of Cigna Corp matters because hiring and staffing trends often say something about growth plans, cost discipline, and management expectations. Current projections suggest a workforce around under 73800 employees by April 2026, which should be reviewed alongside revenue and margin trends.Cigna Corp's latest congressional trading
| 2026-01-16 | Representative Julie Johnson | Acquired Under $15K | Verify | ||
| 2025-12-12 | Representative Julie Johnson | Acquired Under $15K | Verify | ||
| 2025-11-14 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2025-10-08 | Representative Julie Johnson | Acquired Under $15K | Verify | ||
| 2025-10-03 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2025-09-12 | Representative Valerie Hoyle | Acquired Under $15K | Verify | ||
| 2025-06-30 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-01-16 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2020-01-29 | Representative Gerald E Connolly | Acquired Under $15K | Verify | ||
| 2019-09-03 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2019-04-27 | Representative Gerald E Connolly | Acquired Under $15K | Verify | ||
| 2019-02-09 | Representative Alan S Lowenthal | Acquired Under $15K | Verify |
Cigna Corp Management Team Effectiveness
The company has Return on Asset (ROA) of 4.09 % which means that for every $100 of assets, it generated a profit of $4.09. This is typical in the industry. Likewise, it shows a return on total equity (ROE) of 15.13 %, which means that it produced $15.13 on every 100 dollars invested by current stockholders.Cigna Stock Ownership Analysis
About 92.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cigna Corp has Price/Earnings To Growth (PEG) ratio of 0.55. The entity recorded earning per share (EPS) of 22.19. The firm last dividend was issued on the 5th of March 2026. Cigna Corp completed a 3:1 stock split on 5th of June 2007.Cigna Corp Quarterly Liabilities And Stockholders Equity | 157.92 Billion |
Cigna Corp Insider Trades History
Cigna Stock Institutional Investors
| Shares | T. Rowe Price Investment Management,inc. | 2025-09-30 | 3.7 M | Norges Bank | 2025-12-31 | 3.7 M | Morgan Stanley - Brokerage Accounts | 2025-09-30 | 3.7 M | Capital Research Global Investors | 2025-09-30 | 3.2 M | Arrowstreet Capital Limited Partnership | 2025-12-31 | 3 M | Bank Of America Corp | 2025-09-30 | 2.8 M | Northern Trust Corp | 2025-09-30 | 2.8 M | Ubs Asset Mgmt Americas Inc | 2025-09-30 | 2.3 M | Charles Schwab Investment Management Inc | 2025-12-31 | 2.2 M | Vanguard Group Inc | 2025-12-31 | 26.2 M | Blackrock Inc | 2025-09-30 | 22.1 M |
Cigna Corp Insider Trading Activities
Everett Neville over a week ago Insider Trading | ||
Everett Neville over two weeks ago Insider Trading | ||
Everett Neville over two weeks ago Insider Trading | ||
Everett Neville over three weeks ago Insider Trading | ||
Everett Neville over three weeks ago Insider Trading | ||
Everett Neville over three weeks ago Insider Trading | ||
Everett Neville over a month ago Insider Trading | ||
Everett Neville over a month ago Insider Trading | ||
Everett Neville over a month ago Insider Trading | ||
Everett Neville over a month ago Insider Trading | ||
Everett Neville over a month ago Insider Trading | ||
Everett Neville over a month ago Insider Trading |
Cigna Corp Outstanding Bonds
| CIGNA P 7875 Corp BondUS125509AZ26 | View | |
| CIGNA P 305 Corp BondUS125509BV03 | View | |
| CIT Group 6125 Corp BondUS125581GX07 | View | |
| CIGNA P Corp BondUS125523AH38 | View | |
| CIGNA P Corp BondUS125523AK66 | View | |
| CIGNA P Corp BondUS125523AJ93 | View | |
| CIGNA P Corp BondUS125523BK57 | View | |
| US125523AX87 Corp BondUS125523AX87 | View |
Cigna Corp Corporate Filings
13A | 5th of March 2026 An amended filing to the original Schedule 13G | ViewVerify |
8K | 3rd of March 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 27th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 26th of February 2026 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 5th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 2nd of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 18th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 5th of November 2025 An amended filing to the original Schedule 13G | ViewVerify |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 268.2 M | Current Value 265.9 M | Average Shares Outstanding 452.4 M | Quarterly Volatility 184 M |
Cigna Stock Holders Distribution
Cigna Corp Market Cap and Value
Cigna Corp Workforce Comparison
Cigna Corp Profit Margins
The company has Net Profit Margin (PM) of 0.02 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.04 %, which signifies that for every $100 of sales, it has a net operating income of $0.04.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0898 | 0.0945 |
|
| |||||
| Net Profit Margin | 0.0206 | 0.0217 |
|
| |||||
| Operating Profit Margin | 0.0505 | 0.0332 |
|
| |||||
| Pretax Profit Margin | 0.0262 | 0.0276 |
|
|
Cigna Corp Insider Trading History
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 1.4 | 21 | 15 | 159,009 | 29,124 |
| 2025-12-01 | 1.3333 | 4 | 3 | 10,511 | 11,637 |
| 2025-09-01 | 0.8333 | 5 | 6 | 27,530 | 56,246 |
| 2025-03-01 | 1.15 | 23 | 20 | 262,606 | 104,391 |
| 2024-12-01 | 2.0 | 2 | 1 | 224.25 | 50.00 |
| 2024-09-01 | 0.6 | 6 | 10 | 27,766 | 59,387 |
| 2024-06-01 | 1.6667 | 20 | 12 | 25,838 | 42,695 |
| 2024-03-01 | 0.6716 | 45 | 67 | 383,056 | 379,458 |
| 2023-12-01 | 3.0 | 3 | 1 | 63,570 | 63,306 |
| 2023-09-01 | 0.65 | 13 | 20 | 25,282 | 67,408 |
| 2023-06-01 | 4.6667 | 14 | 3 | 8,945 | 1,651 |
| 2023-03-01 | 0.9302 | 40 | 43 | 375,582 | 178,308 |
| 2022-12-01 | 0.7273 | 8 | 11 | 25,129 | 49,407 |
| 2022-09-01 | 0.625 | 10 | 16 | 28,102 | 66,986 |
| 2022-06-01 | 1.0 | 29 | 29 | 102,859 | 251,042 |
| 2022-03-01 | 1.2045 | 53 | 44 | 345,487 | 56,336 |
| 2021-12-01 | 5.0 | 15 | 3 | 44,515 | 41,005 |
| 2021-09-01 | 5.3333 | 16 | 3 | 14,461 | 768.00 |
| 2021-06-01 | 0.725 | 29 | 40 | 352,246 | 644,968 |
| 2021-03-01 | 1.0645 | 66 | 62 | 608,063 | 424,915 |
| 2020-12-01 | 1.1429 | 24 | 21 | 145,754 | 284,598 |
| 2020-09-01 | 2.4444 | 22 | 9 | 35,137 | 31,369 |
| 2020-06-01 | 0.7805 | 32 | 41 | 379,766 | 676,674 |
| 2020-03-01 | 1.186 | 51 | 43 | 397,256 | 181,950 |
| 2019-12-01 | 1.5455 | 17 | 11 | 37,452 | 73,376 |
| 2019-09-01 | 7.0 | 14 | 2 | 36,445 | 628.00 |
| 2019-06-01 | 4.6667 | 14 | 3 | 7,389 | 7,394 |
| 2019-03-01 | 1.8182 | 60 | 33 | 390,673 | 109,918 |
| 2018-12-01 | 3.1818 | 175 | 55 | 3,853,450 | 713,125 |
| 2018-09-01 | 8.0 | 8 | 1 | 4,382 | 238.00 |
| 2018-06-01 | 2.6667 | 8 | 3 | 2,730 | 2,265 |
| 2018-03-01 | 1.2 | 18 | 15 | 83,017 | 57,036 |
| 2017-12-01 | 4.5 | 9 | 2 | 2,195 | 1,150 |
| 2017-09-01 | 1.1538 | 15 | 13 | 65,140 | 127,723 |
| 2017-06-01 | 0.9091 | 10 | 11 | 19,131 | 55,125 |
| 2017-03-01 | 1.6154 | 21 | 13 | 169,725 | 88,331 |
| 2016-12-01 | 2.6667 | 8 | 3 | 2,544 | 6,600 |
| 2016-09-01 | 8.0 | 8 | 1 | 2,674 | 500.00 |
| 2016-06-01 | 4.0 | 8 | 2 | 2,681 | 1,542 |
| 2016-03-01 | 2.0 | 20 | 10 | 216,811 | 90,054 |
| 2015-06-01 | 1.6667 | 10 | 6 | 12,624 | 29,938 |
| 2015-03-01 | 1.0606 | 35 | 33 | 335,228 | 305,047 |
| 2014-12-01 | 3.0 | 9 | 3 | 3,774 | 892.00 |
| 2014-09-01 | 1.2222 | 11 | 9 | 18,550 | 45,759 |
| 2014-06-01 | 0.8571 | 24 | 28 | 112,421 | 143,488 |
| 2014-03-01 | 1.75 | 21 | 12 | 279,218 | 96,415 |
| 2013-12-01 | 1.5 | 9 | 6 | 5,412 | 8,781 |
| 2013-09-01 | 1.2222 | 11 | 9 | 31,803 | 67,688 |
| 2013-06-01 | 1.0 | 17 | 17 | 77,140 | 136,055 |
| 2013-03-01 | 1.3125 | 21 | 16 | 252,350 | 77,637 |
| 2012-12-01 | 0.7778 | 14 | 18 | 13,912 | 11,972 |
| 2012-09-01 | 0.9375 | 15 | 16 | 20,392 | 26,952 |
| 2012-06-01 | 1.0 | 14 | 14 | 18,368 | 21,064 |
| 2012-03-01 | 1.1667 | 21 | 18 | 156,733 | 43,309 |
| 2011-12-01 | 0.6364 | 7 | 11 | 19,950 | 28,977 |
| 2011-09-01 | 0.8 | 8 | 10 | 20,839 | 26,572 |
| 2011-06-01 | 1.4545 | 16 | 11 | 56,230 | 29,348 |
| 2011-03-01 | 0.8182 | 9 | 11 | 44,390 | 15,938 |
| 2010-12-01 | 0.5333 | 8 | 15 | 22,803 | 39,437 |
| 2010-09-01 | 0.6 | 6 | 10 | 4,375 | 6,561 |
| 2010-06-01 | 1.1667 | 14 | 12 | 28,176 | 11,608 |
| 2010-03-01 | 0.7143 | 10 | 14 | 45,078 | 77,882 |
| 2009-12-01 | 1.0625 | 17 | 16 | 171,752 | 617,135 |
| 2009-09-01 | 1.2308 | 16 | 13 | 214,387 | 391,157 |
| 2009-06-01 | 1.3636 | 15 | 11 | 21,581 | 64,393 |
| 2009-03-01 | 1.3846 | 18 | 13 | 563,383 | 30,618 |
| 2008-12-01 | 6.0 | 6 | 1 | 20,531 | 4,730 |
| 2008-09-01 | 0.9 | 9 | 10 | 60,147 | 35,904 |
| 2008-06-01 | 0.0886 | 7 | 79 | 12,061 | 51,411 |
| 2008-03-01 | 0.1304 | 15 | 115 | 671,196 | 298,523 |
| 2007-12-01 | 0.3333 | 8 | 24 | 78,979 | 127,788 |
| 2007-06-01 | 0.217 | 23 | 106 | 130,161 | 210,625 |
| 2007-03-01 | 0.413 | 19 | 46 | 269,347 | 290,904 |
| 2006-12-01 | 0.8571 | 12 | 14 | 127,832 | 235,356 |
| 2006-09-01 | 1.0 | 7 | 7 | 15,416 | 30,183 |
| 2006-06-01 | 8.0 | 8 | 1 | 3,821 | 2,635 |
| 2006-03-01 | 0.7143 | 20 | 28 | 305,621 | 365,782 |
| 2005-12-01 | 0.6667 | 10 | 15 | 172,290 | 315,576 |
| 2005-09-01 | 1.1429 | 16 | 14 | 34,703 | 41,509 |
| 2005-06-01 | 1.1 | 22 | 20 | 67,450 | 69,231 |
| 2005-03-01 | 0.9375 | 15 | 16 | 387,528 | 387,043 |
| 2004-06-01 | 2.0 | 16 | 8 | 160,896 | 177,686 |
| 2004-03-01 | 3.0 | 9 | 3 | 467,958 | 146,056 |
Cigna Corp Notable Stakeholders
| David Cordani | CEO and President Director and Member of Executive Committee | Profile | |
| Timothy Wentworth | Chief Executive Officer - Evernorth | Profile | |
| Isaiah Harris | Independent Chairman of the Board | Profile | |
| Nicole Jones | Executive Vice President, General Counsel | Profile | |
| John Murabito | Executive Vice President - Human Resources, Chief Administrative Officer | Profile | |
| Christopher MBA | President Businesses | Profile | |
| Brian Evanko | Chief Financial Officer, Executive Vice President | Profile | |
| Matt Perlberg | Pharmacy President | Profile | |
| Matthew Manders | President of U.S. Commercial Markets and Global Health Care Operations | Profile | |
| Noelle Eder | Executive Vice President, Global Chief Information Officer | Profile | |
| Eric Palmer | Chief Financial Officer, Executive Vice President | Profile | |
| Dean Mirabella | President Markets | Profile | |
| Mark Boxer | Executive Vice President, Chief Information Officer | Profile | |
| Adam PharmD | President Services | Profile | |
| Jason Sadler | President of International Markets | Profile | |
| Kristen Lauria | Executive Vice President, Chief Marketing Officer | Profile | |
| Everett Neville | Executive Vice President, Strategy, Corporate Development and Solutions | Profile | |
| MICHAEL TRIPLETT | President - U.S. Commercial | Profile | |
| Brian CFA | President Healthcare | Profile | |
| Ann Dennison | Executive CFO | Profile | |
| Donna Zarcone | Independent Director | Profile | |
| Eric Foss | Independent Director | Profile | |
| Roman Martinez | Independent Director | Profile | |
| Kimberly Ross | Independent Director | Profile | |
| John Partridge | Independent Director | Profile | |
| Mark McClellan | Independent Director | Profile | |
| Eric Wiseman | Lead Independent Director | Profile | |
| George Kurian | Independent Director | Profile | |
| Nicole JD | Chief VP | Profile | |
| John Webb | President - Health Care | Profile | |
| Alexis Jones | Investor Principal | Profile | |
| Neesha Hathi | Independent Director | Profile | |
| Ralph Giacobbe | Senior Relations | Profile | |
| Phil Austin | Head Markets | Profile | |
| Elder Granger | Independent Director | Profile | |
| Kari Stevens | Executive Officer | Profile | |
| Terese CPA | Senior Officer | Profile | |
| Charles Berg | President - U.S. Government Business | Profile | |
| Arjan Toor | Chief Operations | Profile | |
| Durga Koka | Executive Officer | Profile | |
| Cynthia Ryan | Chief Human Resource Officer | Profile | |
| William DeLaney | Independent Director | Profile | |
| David Kobus | Market Market | Profile | |
| Paul Sanford | Executive Vice President - Operations | Profile | |
| Jamie Kates | Senior Officer | Profile | |
| Kathleen Mazzarella | Independent Director | Profile | |
| Mary CPA | Senior Officer | Profile | |
| Steven Miller | Executive Vice President Chief Clinical Officer | Profile | |
| Mary Picerno | Chief Officer | Profile | |
| William Roper | Independent Director | Profile |
Cigna Corp Insider Ownership and Executives
Methodology
Unless otherwise specified, financial data for Cigna Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cigna (USA Stocks:CI) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Insider activity and ownership figures are derived from regulatory filings, including SEC Form 4 submissions where applicable.
Assumptions
We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Cigna Corp is covered by 25 analysts. 12 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Citigroup, HSBC Global Research, Stifel, Wells Fargo Securities, UBS Investment Research, RBC Capital Markets, Bank of America Securities, J.P. Morgan, Jefferies, Oppenheimer & Co., among others. Updates may occur throughout the day.
Cigna Corp Workforce Analysis
Cigna Corp Manpower Efficiency
Return on Cigna Corp Manpower
| Revenue Per Employee | 4.2M | |
| Revenue Per Executive | 5.5B | |
| Net Income Per Employee | 95.8K | |
| Net Income Per Executive | 125.8M |
Popular Tools for Cigna Stock analysis
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |